Evidence map›Paper›PMID 19587703›Full record

ArticleLeukemia2009

Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.

J-M Terme, V Mocquet, A-S Kuhlmann, L Zane, F Mortreux, E Wattel, M Duc Dodon, P Jalinot

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

J-M TermeLaboratoire de Biologie Moléculaire de la Cellule, Unité Mixte de Recherche 5239, Centre National de la Recherche Scientifique, Ecole Normale Supérieure de Lyon, Institut Fédératif de Recherche, Lyon cedex 07, France.
V Mocquet
A-S Kuhlmann
L Zane
F Mortreux
E Wattel
M Duc Dodon
P Jalinot
École Normale Supérieure de Lyon · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomerase activity, which has fundamental roles in development and carcinogenesis, strongly depends on the expression of human telomerase reverse transcriptase (hTERT), its catalytic subunit. In this report, we show that the basic helix-loop-helix factor, TAL1 (T-cell acute lymphoblastic leukemia 1), is a negative regulator of the hTERT promoter. Indeed, TAL1 overexpression leads to a decrease in hTERT mRNA abundance and hence to reduced telomerase activity. Conversely, suppression of TAL1 by RNA interference in Jurkat cells increases hTERT expression. Analysis by chromatin immunoprecipitation assays showed that TAL1 binds to the hTERT proximal promoter and recruits HDAC1. Considering the relationship recently established between TAL1 and the human T-cell leukemia virus type 1 (HTLV-1) Tax protein, which was confirmed in T lymphocyte clones derived from adult T-cell leukemia patients, we analyzed the effect of TAL1 with respect to the earlier characterized effects of Tax and HBZ (HTLV-1 basic leucine zipper) on hTERT expression. TAL1 was observed to reinforce the negative effect of Tax, whereas hTERT transactivation by the HBZ-JunD complex was repressed by TAL1 overexpression. Moreover, HBZ was found to induce proteasome-mediated degradation of TAL1. These observations support a model in which Tax and TAL1 by repressing hTERT would initially favor genomic instability, whereas expression of factors such as HBZ allows at a later stage an increase in hTERT production and consequently in telomerase activity.

Indexed as

Basic Helix-Loop-Helix ProteinsBasic-Leucine Zipper Transcription FactorsBinding, CompetitiveGene Expression Regulation, LeukemicGene Products, taxGenomic InstabilityHeLa CellsHumansJurkat CellsLeukemia, T-CellPromoter Regions, GeneticProto-Oncogene ProteinsRetroviridae ProteinsSp1 Transcription FactorT-Cell Acute Lymphocytic Leukemia Protein 1TelomeraseBasic Helix-Loop-Helix ProteinsBasic-Leucine Zipper Transcription FactorsGene Products, taxHBZ protein, human T-cell leukemia virus type IProto-Oncogene ProteinsRetroviridae ProteinsSp1 Transcription FactorTAL1 protein, humantax protein, Human T-lymphotrophic virus 1T-Cell Acute Lymphocytic Leukemia Protein 1TelomeraseTERT protein, humanViral Proteins

Identifiers

PMID19587703
OpenAlexW2065929921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.